MIRVIE, INC.

ENCOMPASS

Medical testing for diagnostic or treatment purposes;

ENCOMPASS PREECLAMPSIA

Medical testing for diagnostic or treatment purposes;

ENCOMPASS PREECLAMPSIA PREDICTOR

Medical testing for diagnostic or treatment purposes;

ENCOMPASS PREECLAMPSIA SCREEN

Medical testing for diagnostic or treatment purposes;

ENCOMPASS PREECLAMPSIA TEST

Medical testing for diagnostic or treatment purposes;

ENCOMPASS PREGNANCY

Medical testing for diagnostic or treatment purposes;

MIRVIE

Medical information; provision of medical information and data on fertility; providing a website featuring medical information, namely, providing information concerning fertility, ovulation, pregnancy, and birth risks; providing information by means of a website in connection with predicting, screening, diagnosing, and monitoring of various pre-conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; providing information by means of a website in connection with whether fetal development is proceeding normally or abnormally;

MIRVIE

Recorded computer software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks in the field of obstetrics and labor and delivery; Downloadable computer software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks; Recorded computer software for use in connection with predicting, screening, diagnosing, and monitoring of various pre-conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; Downloadable computer software for use in connection with assessing whether fetal development is proceeding normally or abnormally;Medical apparatus for predicting pregnancy due date or estimating gestational age; medical apparatus for predicting, screening, diagnosing, and monitoring of various pre-conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; medical apparatus for assessing whether fetal development is proceeding normally or abnormally;Software as a service (SAAS) services, namely, hosting software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks in the field of obstetrics and labor and delivery; software as a service (SAAS) services, namely, hosting software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks; software as a service (SAAS) services featuring software for use in connection with predicting, screening, diagnosing, and monitoring of various pre-conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; software as a service (SAAS) services featuring software for use in connection with assessing whether fetal development is proceeding normally or abnormally;